Global Cancer Biomarkers Market Research Report 2016

October 2016 | 106 pages | ID: G35C80DC0A4EN
QYResearch

Abstracts

Notes:

Production, means the output of Cancer Biomarkers

Revenue, means the sales value of Cancer Biomarkers

This report studies Cancer Biomarkers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Abbott Laboratories (U.S.)
• Affymetrix Inc. (U.S.)
• Roche Diagnostics Ltd. (Switzerland)
• Illumina, Inc. (U.S.)
• Qiagen NV (Netherlands)
• Agilent Technologies (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Merck & Co. Inc. (U.S.)
• Becton Dickinson and Company (U.S.)
• Hologic Inc. (U.S.)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Cancer Biomarkers in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Protein Biomarkers
• Genetic Biomarkers
• Others

Split by application, this report focuses on consumption, market share and growth rate of Cancer Biomarkers in each application, can be divided into

• Diagnostics
• Drug Discovery and Development
• Prognostics
• Risk Assessment
• Others?

Contents

Global Cancer Biomarkers Market Research Report 2016

1 CANCER BIOMARKERS MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Biomarkers
1.2 Cancer Biomarkers Segment by Type
  1.2.1 Global Production Market Share of Cancer Biomarkers by Type in 2015
  1.2.2 Protein Biomarkers
  1.2.3 Genetic Biomarkers
Others
1.3 Cancer Biomarkers Segment by Application
  1.3.1 Cancer Biomarkers Consumption Market Share by Application in 2015
  1.3.2 Diagnostics
  1.3.3 Drug Discovery and Development
  1.3.4 Prognostics
  1.3.5 Risk Assessment
  1.3.6 Others?
1.4 Cancer Biomarkers Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Cancer Biomarkers (2011-2021)

2 GLOBAL CANCER BIOMARKERS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Cancer Biomarkers Production and Share by Manufacturers (2015 and 2016)
2.2 Global Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Cancer Biomarkers Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Cancer Biomarkers Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Biomarkers Market Competitive Situation and Trends
  2.5.1 Cancer Biomarkers Market Concentration Rate
  2.5.2 Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Cancer Biomarkers Production by Region (2011-2016)
3.2 Global Cancer Biomarkers Production Market Share by Region (2011-2016)
3.3 Global Cancer Biomarkers Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL CANCER BIOMARKERS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Cancer Biomarkers Consumption by Regions (2011-2016)
4.2 North America Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Cancer Biomarkers Production and Market Share by Type (2011-2016)
5.2 Global Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
5.3 Global Cancer Biomarkers Price by Type (2011-2016)
5.4 Global Cancer Biomarkers Production Growth by Type (2011-2016)

6 GLOBAL CANCER BIOMARKERS MARKET ANALYSIS BY APPLICATION

6.1 Global Cancer Biomarkers Consumption and Market Share by Application (2011-2016)
6.2 Global Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL CANCER BIOMARKERS MANUFACTURERS PROFILES/ANALYSIS

7.1 Abbott Laboratories (U.S.)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Cancer Biomarkers Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Abbott Laboratories (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Affymetrix Inc. (U.S.)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Cancer Biomarkers Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Affymetrix Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Roche Diagnostics Ltd. (Switzerland)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Cancer Biomarkers Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Illumina, Inc. (U.S.)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Cancer Biomarkers Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Illumina, Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Qiagen NV (Netherlands)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Cancer Biomarkers Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Qiagen NV (Netherlands) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Agilent Technologies (U.S.)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Cancer Biomarkers Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Agilent Technologies (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Thermo Fisher Scientific Inc. (U.S.)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Cancer Biomarkers Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Merck & Co. Inc. (U.S.)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Cancer Biomarkers Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Merck & Co. Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Becton Dickinson and Company (U.S.)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Cancer Biomarkers Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Becton Dickinson and Company (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Hologic Inc. (U.S.)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Cancer Biomarkers Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Hologic Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 CANCER BIOMARKERS MANUFACTURING COST ANALYSIS

8.1 Cancer Biomarkers Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Biomarkers

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Cancer Biomarkers Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL CANCER BIOMARKERS MARKET FORECAST (2016-2021)

12.1 Global Cancer Biomarkers Production, Revenue Forecast (2016-2021)
12.2 Global Cancer Biomarkers Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Cancer Biomarkers Production Forecast by Type (2016-2021)
12.4 Global Cancer Biomarkers Consumption Forecast by Application (2016-2021)
12.5 Cancer Biomarkers Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Biomarkers
Figure Global Production Market Share of Cancer Biomarkers by Type in 2015
Figure Product Picture of Protein Biomarkers
Table Major Manufacturers of Protein Biomarkers
Figure Product Picture of Genetic Biomarkers
Table Major Manufacturers of Genetic Biomarkers
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Cancer Biomarkers Consumption Market Share by Application in 2015
Figure Diagnostics Examples
Figure Drug Discovery and Development Examples
Figure Prognostics Examples
Figure Risk Assessment Examples
Figure Others? Examples
Figure North America Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Cancer Biomarkers Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Cancer Biomarkers Capacity of Key Manufacturers (2015 and 2016)
Table Global Cancer Biomarkers Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Cancer Biomarkers Capacity of Key Manufacturers in 2015
Figure Global Cancer Biomarkers Capacity of Key Manufacturers in 2016
Table Global Cancer Biomarkers Production of Key Manufacturers (2015 and 2016)
Table Global Cancer Biomarkers Production Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Biomarkers Production Share by Manufacturers
Figure 2016 Cancer Biomarkers Production Share by Manufacturers
Table Global Cancer Biomarkers Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 Global Cancer Biomarkers Revenue Share by Manufacturers
Table Global Market Cancer Biomarkers Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Cancer Biomarkers Average Price of Key Manufacturers in 2015
Table Manufacturers Cancer Biomarkers Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Biomarkers Product Type
Figure Cancer Biomarkers Market Share of Top 3 Manufacturers
Figure Cancer Biomarkers Market Share of Top 5 Manufacturers
Table Global Cancer Biomarkers Capacity by Regions (2011-2016)
Figure Global Cancer Biomarkers Capacity Market Share by Regions (2011-2016)
Figure Global Cancer Biomarkers Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Cancer Biomarkers Capacity Market Share by Regions
Table Global Cancer Biomarkers Production by Regions (2011-2016)
Figure Global Cancer Biomarkers Production and Market Share by Regions (2011-2016)
Figure Global Cancer Biomarkers Production Market Share by Regions (2011-2016)
Figure 2015 Global Cancer Biomarkers Production Market Share by Regions
Table Global Cancer Biomarkers Revenue by Regions (2011-2016)
Table Global Cancer Biomarkers Revenue Market Share by Regions (2011-2016)
Table 2015 Global Cancer Biomarkers Revenue Market Share by Regions
Table Global Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Table China Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Table India Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Cancer Biomarkers Consumption Market by Regions (2011-2016)
Table Global Cancer Biomarkers Consumption Market Share by Regions (2011-2016)
Figure Global Cancer Biomarkers Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Cancer Biomarkers Consumption Market Share by Regions
Table North America Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)
Table Europe Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)
Table China Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)
Table Japan Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)
Table India Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)
Table Global Cancer Biomarkers Production by Type (2011-2016)
Table Global Cancer Biomarkers Production Share by Type (2011-2016)
Figure Production Market Share of Cancer Biomarkers by Type (2011-2016)
Figure 2015 Production Market Share of Cancer Biomarkers by Type
Table Global Cancer Biomarkers Revenue by Type (2011-2016)
Table Global Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Cancer Biomarkers by Type (2011-2016)
Figure 2015 Revenue Market Share of Cancer Biomarkers by Type
Table Global Cancer Biomarkers Price by Type (2011-2016)
Figure Global Cancer Biomarkers Production Growth by Type (2011-2016)
Table Global Cancer Biomarkers Consumption by Application (2011-2016)
Table Global Cancer Biomarkers Consumption Market Share by Application (2011-2016)
Figure Global Cancer Biomarkers Consumption Market Share by Application in 2015
Table Global Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
Figure Global Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
Table Abbott Laboratories (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Affymetrix Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Affymetrix Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Illumina, Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Illumina, Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Qiagen NV (Netherlands) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qiagen NV (Netherlands) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Qiagen NV (Netherlands) Cancer Biomarkers Market Share (2011-2016)
Table Agilent Technologies (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agilent Technologies (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Agilent Technologies (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Merck & Co. Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Becton Dickinson and Company (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Becton Dickinson and Company (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Hologic Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hologic Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hologic Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Biomarkers
Figure Manufacturing Process Analysis of Cancer Biomarkers
Figure Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Cancer Biomarkers
Table Distributors/Traders List
Figure Global Cancer Biomarkers Production and Growth Rate Forecast (2016-2021)
Figure Global Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table Global Cancer Biomarkers Production Forecast by Regions (2016-2021)
Table Global Cancer Biomarkers Consumption Forecast by Regions (2016-2021)
Table Global Cancer Biomarkers Production Forecast by Type (2016-2021)
Table Global Cancer Biomarkers Consumption Forecast by Application (2016-2021)